Operative Therapie des Mammakarzinoms unter onkologischen Aspekten

Michael Friedrich; T. Kühn; W. Janni; V. Müller; M. Banys-Paluchowski; N. Ditsch

Operative Therapie des Mammakarzinoms unter onkologischen Aspekten

Michael Friedrich, T. Kühn, W. Janni, V. Müller, M. Banys-Paluchowski, N. Ditsch

Abstract

The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO) provides annual recommendations on the prevention, diagnosis and treatment of breast cancer. In the current update for axillary surgery, the presence of micrometastases and isolated tumor cells after Neoadjuvant Chemotherapy (NACT) and the clinical consequences of low volume axillary involvement assessed by SLNE and TAD were included for the first time. This article gives an overview of this year’s AGO recommendations for surgical management of the axilla in primary surgery of breast cancer and in the context of neoadjuvant treatment.

Titel in Übersetzung	Surgical Treatment of Breast Cancer und oncological aspects. Axillary staging: when and how much is necessary?
Originalsprache	Deutsch
Zeitschrift	Gynakologische Praxis
Jahrgang	51
Ausgabenummer	2
Seiten (von - bis)	270-281
Seitenumfang	12
ISSN	0341-8677
Publikationsstatus	Veröffentlicht - 2023

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

Profilbereich: Lübeck Integrated Oncology Network (LION)
Zentren: Universitäres Cancer Center Schleswig-Holstein (UCCSH)

DFG-Fachsystematik

2.22-14 Hämatologie, Onkologie
2.22-21 Gynäkologie und Geburtshilfe

Weitere Links

Link to publication in Scopus

Zitieren

@article{1f92930178d7483d8d6cc86ca43689d8,

title = "Operative Therapie des Mammakarzinoms unter onkologischen Aspekten",

abstract = "The Breast Committee of the Arbeitsgemeinschaft Gyn{\"a}kologische Onkologie (German Gynecological Oncology Group, AGO) provides annual recommendations on the prevention, diagnosis and treatment of breast cancer. In the current update for axillary surgery, the presence of micrometastases and isolated tumor cells after Neoadjuvant Chemotherapy (NACT) and the clinical consequences of low volume axillary involvement assessed by SLNE and TAD were included for the first time. This article gives an overview of this year{\textquoteright}s AGO recommendations for surgical management of the axilla in primary surgery of breast cancer and in the context of neoadjuvant treatment.",

author = "Michael Friedrich and T. K{\"u}hn and W. Janni and V. M{\"u}ller and M. Banys-Paluchowski and N. Ditsch",

year = "2023",

language = "Deutsch",

volume = "51",

pages = "270--281",

journal = "Gynakologische Praxis",

issn = "0341-8677",

publisher = "Mediengruppe Oberfranken - Fachverlage GmbH \& Co. KG",

number = "2",

}

TY - JOUR

T1 - Operative Therapie des Mammakarzinoms unter onkologischen Aspekten

AU - Friedrich, Michael

AU - Kühn, T.

AU - Janni, W.

AU - Müller, V.

AU - Banys-Paluchowski, M.

AU - Ditsch, N.

PY - 2023

Y1 - 2023

N2 - The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO) provides annual recommendations on the prevention, diagnosis and treatment of breast cancer. In the current update for axillary surgery, the presence of micrometastases and isolated tumor cells after Neoadjuvant Chemotherapy (NACT) and the clinical consequences of low volume axillary involvement assessed by SLNE and TAD were included for the first time. This article gives an overview of this year’s AGO recommendations for surgical management of the axilla in primary surgery of breast cancer and in the context of neoadjuvant treatment.

AB - The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO) provides annual recommendations on the prevention, diagnosis and treatment of breast cancer. In the current update for axillary surgery, the presence of micrometastases and isolated tumor cells after Neoadjuvant Chemotherapy (NACT) and the clinical consequences of low volume axillary involvement assessed by SLNE and TAD were included for the first time. This article gives an overview of this year’s AGO recommendations for surgical management of the axilla in primary surgery of breast cancer and in the context of neoadjuvant treatment.

UR - https://www.scopus.com/pages/publications/85173473921

M3 - Zeitschriftenaufsätze

AN - SCOPUS:85173473921

SN - 0341-8677

VL - 51

SP - 270

EP - 281

JO - Gynakologische Praxis

JF - Gynakologische Praxis

IS - 2

ER -

Operative Therapie des Mammakarzinoms unter onkologischen Aspekten

Abstract

UN SDGs

Strategische Forschungsbereiche und Zentren

DFG-Fachsystematik

Weitere Links

Fingerprint

Zitieren